Topic: Pharmaceutical

Pear Therapeutics today announced the publication of positive results from real-world data of its reSET-O […]

The FDA improved an Impel NeuroPharma migraine treatment, a nasal spray intended to bring pain relief more quickly than drugs administered in other ways. It marks the first approval for the Seattle company, which has developed a proprietary nasal delivery technology.

The regulatory decision clears the way for more vaccine mandates in the U.S.

MedAlliance announced today that it enrolled the first patient in an erectile dysfunction (ED) feasibility study […]

Verily’s recent moves have signaled the company’s interest in supporting decentralized clinical trials and real-world studies. Now the life sciences subsidiary of Alphabet is bolstering its capabilities in these areas with the acquisition of startup SignalPath.

Eli Lilly (NYSE:LLY) today announced executive leadership changes as it creates neuroscience and immunology business […]

Sanofi has struck a deal to buy its mRNA partner Translate Bio in a $3.2 billion deal. […]

The engineered viruses used to deliver gene therapies can spark complications and they can’t be re-dosed. Ring Therapeutics says viruses that evolved with humans can be better viral vectors and the startup has raised $117 million in new financing to continue its research.

Amgen is paying $900 million up front to acquire Teneobio, a biotech with technology for discovering and developing antibody drugs. Though Amgen already has its own antibody platform, the company says Teneobio’s technology and drug assets will complement its own.

United Therapeutics (NSDQ:UTHR) today announced positive results from an analysis of forced vital capacity (FVC) change […]

Genentech announced that the FDA accepted its Biologics License Application (BLA) for its Port Delivery […]

Cardinal Health (NYSE:CAH) announced today that the FDA approved its Lymphoseek injection for pediatric use. […]

Neurodon announced today that it initiated studies to prepare an FDA Investigational New Drug (IND) […]

Cystic fibrosis drugs are the mainstay of the Vertex Pharmaceuticals portfolio now, but the company […]

Glaukos (NYSE:GKOS) announced today that it entered into a licensing agreement with Intratus over its […]

Genentech announced today that the FDA approved its supplemental biologics license application for the Xolair […]

A Covid-19 antibody cocktail developed by Regeneron Pharmaceuticals and Roche has pivotal clinical trial data […]

Teva Pharmaceuticals announced today that it received European marketing authorization for its Seffalair and BroPair […]

Kindeva Drug Delivery and Cambridge Healthcare Innovations announced a collaboration to commercialize the latter’s dry-powder […]

Long-term stabilization and platelet storage product developer Cellphire Therapeutics announced that it closed a $15 […]

Fresenius Kabi announced that it entered into a U.S. distribution agreement with Corvida Medical for […]

Lyndra Therapeutics announced today that it appointed Abigail Jenkins and Jacqueline Fernandes to executive positions […]

Eliem Therapeutics has exited stealth with $80 million and plans to treat chronic pain, depression, […]

Research published today has highlighted potential growth down the line in the transdermal drug delivery […]

Eyenovia (NSDQ:EYEN) today announced positive results from a study of its microdose array print (MAP) pupil […]

Oramed Pharmaceuticals (NSDQ:ORMP) announced that it reached 25% randomization in the enrollment for its oral […]

Savara (NSDQ:SVRA) announced today that it closed its previously announced public offering with proceeds reaching […]

Takeda Pharmaceutical (NYSE:TAK) announced that it is acquiring Maverick Therapeutics in a deal worth up […]

Merck (NYSE:MRK) today announced positive results from a Phase 1 study of its subdermal drug-eluting implant […]

Becton Dickinson (NYSE:BDX) announced today that it acquired smart medication device developer GSL solutions for an […]

Vividion Therapeutics has technology that finds ways to hit promising disease targets that were previously […]

Acorda Therapeutics (NSDQ:ACOR) announced today that its chief of business operations, David Lawrence, is resigning from […]

ForDoz Pharma announced today that it entered into an agreement with LipoMedix to manufacture its […]

Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) announced today that they received conditional authorization from European regulators. The […]

Deep Genomics is wasting no time. Two weeks after hiring a new chief business officer […]

Pfizer (NYSE:PFE) and its partner BioNTech (NSDQ:BNTX) announced that they will submit a request today with […]

Vibalogics announced that it initiated the first phase of its planned $150 million investment in a […]

PHILADELPHIA, Oct. 16, 2020 /PRNewswire/ — Enterin, Inc., a privately held, CNS-focused pharmaceutical company based in Philadelphia and developing novel […]